Ecully
France
2
2019-11-28
2
2021-12-07
These are the the leading inventors for applications assigned to Amolyt Pharma:
Amolyt Pharma based in Ecully, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders
#2 | 2018-08-16 โ Patent 10,947,285 granted on 2021-03-16Compounds, compositions and uses thereof for improvement of bone disorders
Also check out Amolyt Pharma's (Ecully, France) applicant profile with 3 patent applications submitted.
586230 โ